Bloomage BioTechnology Corporation Limited's (SHSE:688363) Market Cap Surged CN¥2.2b Last Week, Private Equity Firms Who Have a Lot Riding on the Company Were Rewarded

Simply Wall StDec 12 22:32 ET

Does Bloomage BioTechnology (SHSE:688363) Have A Healthy Balance Sheet?

Simply Wall StNov 27 19:53 ET

Bloomage Biotechnology Corporation Limited (688363.SH): China Life Insurance and Chengda collectively shareholding 1.00% of the company's shares.

On November 11, Geruihui: bloomage biotechnology corporation limited (688363.SH) announced that as of November 11, 2024, Guoshou Chengda reduced its holdings of the company's shares by 4,634,782 shares through centralized auction trading, and reduced its holdings of the company's shares by 182,000 shares through bulk trading, totaling a reduction of 4,816,782 shares, accounting for 1.00% of the total shares of the company. After this equity change, Guoshou Chengda holds 29,616,504 shares of the company, accounting for 6.15% of the total shares of the company.

Gelonghui FinanceNov 11 04:40 ET

Bloomage BioTechnology's (SHSE:688363) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Simply Wall StNov 6 18:13 ET

gtja: Q3 cosmetics retail off-season compared to weakened, Hong Kong stock beauty companies' hold positions increased compared to the previous period.

In the third quarter, the cosmetic industry has a relatively scattered landscape, with significant differences in the operating pace of each company against the backdrop of weak overall industry demand.

Zhitong FinanceNov 4 02:32 ET

Huaxi Biotech: Huaxi Biotech\'s 2024 Third Quarter Report

SZSIOct 30 12:00 ET · Announcements